Early Neurologic Abnormalities Associated with Human T-Cell Lymphotropic Virus Type 1 Infection in a Cohort of Peruvian Children

Journal of Pediatrics

Volumn 155, Issue 5, 2009, Pages 700-706

  Kendall, Emily A ^a   González, Elsa ^b   Espinoza, Iván ^b,c   Tipismana, Martín ^b,c   Verdonck, Kristien ^b,d   Clark, Daniel ^b,e   Vermund, Sten H ^a   Gotuzzo, Eduardo ^b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANAMNESIS; ARTICLE; BABINSKI REFLEX; CHILD; CLONUS; COHORT ANALYSIS; CONSTIPATION; CONTROLLED STUDY; DERMATITIS; DISEASE ASSOCIATION; DYSESTHESIA; FATIGUE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HYPERREFLEXIA; LIMB WEAKNESS; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PARESTHESIA; PERU; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; URINARY URGENCY; URINE INCONTINENCE; URINE RETENTION;

ADOLESCENT; AGE DISTRIBUTION; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; NEUROLOGIC EXAMINATION; ODDS RATIO; PARAPARESIS; PARAPARESIS, TROPICAL SPASTIC; PERU; PREVALENCE; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SPINAL CORD DISEASES; TIME FACTORS; URINATION DISORDERS;

EID: 71849120250     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.05.027     Document Type: Article

References (57)

1. Edlich R.F., Arnette J.A., and Williams F.M. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 18 (2000) 109-119
2. Gotuzzo E., Arango C., de Queiroz-Campos A., and Istúriz R.E. Human T-cell lymphotropic virus-I in Latin America. Infect Dis Clin North Am 14 (2000) 211-239
3. Verdonck K., González E., Van Dooren S., Vandamme A., Vanham G., and Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7 (2007) 266-281
4. Robert-Guroff M., Weiss S.H., Giron J.A., Jennings A.M., Ginzburg H.M., Margolis I.B., et al. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA 255 (1986) 3133-3137
5. Kelen G.D., DiGiovanna T.A., Lofy L., Junkins E., Stein A., Sivertson K.T., et al. Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department. Ann Intern Med 113 (1990) 368-372
6. Araujo A.Q.C., and Silva M.T.T. The HTLV-1 neurological complex. Lancet Neurol 5 (2006) 1068-1076
7. Carod-Artal F.J., Mesquita H.M., and Ribeiro L.D.S. Neurological symptoms and disability in HTLV-1 associated myelopathy. Neurologia 23 (2008) 78-84
8. Olindo S., Cabre P., Lézin A., Merle H., Saint-Vil M., Signate A., et al. Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 63 (2006) 1560-1566
9. Nakamura T. Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Med 32 (2000) 600-607
10. Gotuzzo E., Cabrera J., Deza L., Verdonck K., Vandamme A., Cairampoma R., et al. Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 39 (2004) 939-944
11. Maloney E.M., Cleghorn F.R., Morgan O.S., Rodgers-Johnson P., Cranston B., Jack N., et al. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 17 (1998) 167-170
12. Krämer A., Maloney E.M., Morgan O.S., Rodgers-Johnson P., Manns A., Murphy E.L., et al. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. Am J Epidemiol 142 (1995) 1212-1220
13. Zaninovic V. Tropical spastic paraparesis. Lancet 2 (1987) 280
14. Araújo A.P.Q.C., Fontenelle L.M.C., and Pádua P.A.B. Maia Filho HS, Araújo ADQC. Juvenile human T lymphotropic virus type 1-associated myelopathy. Clin Infect Dis 35 (2002) 201-204
15. Primo J.R.L., Brites C., Oliveira M.D.F.S.P.D., Moreno-Carvalho O., Machado M., and Bittencourt A.L. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence. Clin Infect Dis 41 (2005) 535-541
16. de Oliveira M.D.F.S.P., Bittencourt A.L., Brites C., Soares G., Hermes C., and Almeida F.O. HTLV-I associated myelopathy/tropical spastic paraparesis in a 7-year-old boy associated with infective dermatitis. J Neurol Sci 222 (2004) 35-38
17. LaGrenade L., Morgan C., Carberry C., Hanchard B., Fletcher V., Gray R., et al. Tropical spastic paraparesis occurring in HTLV-1 associated infective dermatitis: report of two cases. West Indian Med J 44 (1995) 34-35
18. Osame M., Igata A., Usuku K., Rosales R.L., and Matsumoto M. Mother-to-child transmission in HTLV-I associated myelopathy. Lancet 1 (1987) 106
19. Quintas S., Moreno T., Lobo-Antunes N., and Levy-Gomes A. Tropical spastic paraparesis and HTLV-I associated myelopathy in infancy: a case report and review of the literature. Rev Neurol 39 (2004) 1133-1136
20. Bittencourt A.L., Primo J., and Oliveira M.F.P.D. Manifestations of the human T-cell lymphotropic virus type I infection in childhood and adolescence. J Pediatr (Rio J) 82 (2006) 411-420
21. Farre L., de Oliveira M.D.F.P., Primo J., Vandamme A., Van Weyenbergh J., and Bittencourt A.L. Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia/lymphoma. Clin Infect Dis 46 (2008) 440-442
22. Maloney E.M., Wiktor S.Z., Palmer P., Cranston B., Pate E.J., and Cohn S. A cohort study of health effects of human T-cell lymphotropic virus type I infection in Jamaican children. Pediatrics 112 (2003) e136-e142
23. Nakagawa M., Izumo S., Ijichi S., Kubota H., Arimura K., Kawabata M., et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1 (1995) 50-61
24. Carod-Artal F.J., del Negro M.C., Vargas A.P., and Rizzo I. Cerebellar syndrome and peripheral neuropathy as manifestations of infection by HTLV-1 human T-cell lymphotropic virus. Rev Neurol 29 (1999) 932-935
25. Román G.C., and Osame M. Identity of HTLV-I-associated tropical spastic paraparesis and HTLV-I-associated myelopathy. Lancet 1 (1988) 651
26. LaGrenade L., Hanchard B., Fletcher V., Cranston B., and Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 336 (1990) 1345-1347
27. La Grenade L. HTLV-I, infective dermatitis, and tropical spastic paraparesis. Mol Neurobiol 8 (1994) 147-153
28. Oliveira M.D.F.S.P.D., Brites C., Ferraz N., Magalhaes P., Almeida F., and Bittencourt A.L. Infective dermatitis associated with the human T cell lymphotropic virus type I in Salvador, Bahia, Brazil. Clin Infect Dis 40 (2005) e90-e96
29. Kaplan J.E., Osame M., Kubota H., Igata A., Nishitani H., Maeda Y., et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 3 (1990) 1096-1101
30. Bittencourt A.L., Oliveira M.D.F., Brites C., Van Weyenbergh J., da Silva Vieira M.D.G., and Araújo I. Histopathological and immunohistochemical studies of infective dermatitis associated with HTLV-I. Eur J Dermatol 15 (2005) 26-30
31. Montano S.M., Zunt J.R., Rodriguez L., Quispe I., Rodriguez C., Altamirano J., et al. Human T cell lymphotropic virus type 1 infection and early neurologic development: a pilot study of 48 children. Clin Infect Dis 39 (2004) 1079-1082
32. Goncalves D.U., Proietti F.A., Barbosa-Stancioli E.F., Martins M.L., Ribas J.G., and Martins-Filho O.A. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network. Inflamm Allergy Drug Targets 7 (2008) 98-107
33. Matsuoka M. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2 (2005) 227
34. Shinzato O., Kamihira S., Ikeda S., Kondo H., Kanda T., and Nagata Y. Relationship between the anti-HTLV-1 antibody level, the number of abnormal lymphocytes and the viral-genome dose in HTLV-1-infected individuals. Int J Cancer 54 (1993) 208-212
35. Tschachler E., and Franchini G. Infective Dermatitis: A pabulum for human T-lymphotrophic virus type i leukemogenesis?. Arch Dermatol 134 (1998) 487-488
36. LaGrenade L., Sonoda S., Miller W., Pate E., Rodgers-Johnson P., Hanchard B., et al. HLA DRB1*DQB1* haplotype in HTLV-I-associated familial infective dermatitis may predict development of HTLV-I-associated myelopathy/tropical spastic paraparesis. Am J Med Genet 61 (1996) 37-41
37. Alarcón J.O., Friedman H.B., Montano S.M., Zunt J.R., Holmes K.K., and Quinnan G.V. High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in Peru. J Acquir Immune Defic Syndr 42 (2006) 604-609
38. World Health Organization (WHO). Scientific Group on HTLV-I Infections and Associated Diseases: report (1989), WHO, Manila
39. De Castro-Costa C.M., Araújo A.Q.C., Barreto M.M., Takayanagui O.M., Sohler M.P., da Silva E.L.M., et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses 22 (2006) 931-935
40. Gotuzzo E., Moody J., Verdonck K., Cabada M.M., González E., Van Dooren S., et al. Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis. Rev Panam Salud Publica 22 (2007) 223-230
41. Ureta-Vidal A., Angelin-Duclos C., Tortevoye P., Murphy E., Lepère J.F., Buigues R.P., et al. Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer 82 (1999) 832-836
42. Li H., Biggar R.J., Miley W.J., Maloney E.M., Cranston B., Hanchard B., et al. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis 190 (2004) 1275-1278
43. Maloney E.M., Hisada M., Palmer P., Brooks K., Pate E., Wiktor S.Z., et al. Human T cell lymphotropic virus type I-associated infective dermatitis in Jamaica: a case report of clinical and biologic correlates. Pediatr Infect Dis J 19 (2000) 560-565
44. Fujino T., and Nagata Y. HTLV-I transmission from mother to child. J Reprod Immunol 47 (2000) 197-206
45. Bittencourt A.L., Sabino E.C., Costa M.C., Pedroso C., and Moreira L. No evidence of vertical transmission of HTLV-I in bottle-fed children. Rev Inst Med Trop Sao Paulo 44 (2002) 63-65
46. Takezaki T., Tajima K., Ito M., Ito S., Kinoshita K., Tachibana K., et al. Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I: the Tsushima ATL Study Group. Leukemia 11 (1997) s360-s362
47. Oki T., Yoshinaga M., Otsuka H., Miyata K., Sonoda S., and Nagata Y. A sero-epidemiological study on mother-to-child transmission of HTLV-I in southern Kyushu. Japan. Asia Oceania J Obstet Gynaecol 18 (1992) 371-377
48. Takahashi K., Takezaki T., Oki T., Kawakami K., Yashiki S., Fujiyoshi T., et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I: the Mother-to-Child Transmission Study Group. Int J Cancer 49 (1991) 673-677
49. Wiktor S.Z., Pate E.J., Rosenberg P.S., Barnett M., Palmer P., Medeiros D., et al. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1 (1997) 37-44
50. Pombo-de-Oliveira M.S., Carvalho S.M., Borducchi D., Dobbin J., Salvador J., Correa R.B., et al. Adult T-cell leukemia/lymphoma and cluster of HTLV-I associated diseases in Brazilian settings. Leuk Lymphoma 42 (2001) 135-144
51. Adaui V., Verdonck K., Best I., González E., Tipismana M., Arévalo J., et al. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. J Neurovirol 12 (2006) 456-465
52. Ramirez E., Fernandez J., Cartier L., Villota C., and Rios M. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients. Virus Res 91 (2003) 231-239
53. Nagai M., Utsunomiya T., Takenouchi N., Izumo S., and Osame M. Failure to detect HTLV type 1 DNA from HTLV type 1-seronegative patients with chronic progressive spastic paraparesis in Kagoshima. AIDS Res Hum Retroviruses 18 (2002) 1089-1090
54. Costa C.M., Goubau P., Liu H.F., Vandamme A.M., da Cunha F.M., Santos T.J., et al. HTLV-negative and HTLV type I-positive tropical spastic paraparesis in northeastern Brazil. AIDS Res Hum Retroviruses 11 (1995) 315-318
55. Castro-Costa C.M., Carton H., and Santos T.J. HTLV-I negative tropical spastic paraparesis: a scientific challenge. Arq Neuropsiquiatr 59 (2001) 289-294
56. Lima M.A., Harab R.C., Schor D., Andrada-Serpa M.J., and Araújo A.Q.C. Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 13 (2007) 468-473
57. Araújo A.Q., Leite A.C., Dultra S.V., and Andrada-Serpa M.J. Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 129 (1995) 147-151